Cognition Therapeutics (CGTX) Stock Price & Financial Analysis
Cognition Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Cognition Therapeutics
What is the current stock price for CGTX?
As of the latest trading session, CGTX stock trades at $1.02. The 52-week range is $0.29–$3.83, with a day range of $0.97–$1.61.
What is the P/E ratio for CGTX?
The P/E ratio (Price-to-Earnings) for CGTX is shown in the Key Statistics section. This valuation metric helps compare Cognition Therapeutics, Inc. to industry peers.
Does CGTX pay dividends?
Cognition Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CGTX?
Analyst ratings and recommendations for CGTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CGTX?
Cognition Therapeutics's market capitalization is $91.0M, classifying it as a micro-cap company. Cognition Therapeutics operates in the Healthcare sector within the Biotechnology industry.